Skip to main content

Table 2 Demographic and clinical data of studied patients

From: Short-term outcome following postoperative enhanced recovery implementation in patients with perforated peptic ulcer

Variables

Study (n = 30)

Control (n = 30)

X2/t

P value

Age (years) mean ± SD

40.43 ± 8.39

39.53 ± 8.08

0.423

0.674

Age group n (%)

 18 > 30 years n (%)

3 (10.0)

4 (13.3)

0.363

0.948

 30 > 40 years n (%)

15 (50.0)

16 (53.3)

 40 > 50 years n (%)

7 (23.3)

6 (20.0)

 50–65 years n (%)

5 (16.7)

4 (13.3)

Gender

 Male n (%)

17 (56.7)

21 (70.0)

1.148

0.284

 Female n (%)

13 (43.3)

9 (30.0)

Predisposing factors for perforated peptic ulcer

 History of peptic ulcer treatment n (%)

7 (23.3)

11 (36.7)

1.270

0.260

 Smoking n (%)

7 (23.3)

14 (46.7)

3.590

0.058

 Stress n (%)

16 (53.3)

14 (46.7)

0.267

0.606

 NSAIDs use n (%)

15 (50.0)

20 (66.7)

1.714

0.190

 Spicy food n (%)

4 (13.3)

9 (30)

2.455

0.117

Current health history

 Co-morbid n (%)

4 (13.3)

7 (23.3)

1.002

0.317

 Shock on admission n (%)

25 (83.3)

27 (90.0)

0.577

0.448

 Delayed surgery > 6 h. of admission n (%)

16 (53.3)

18 (60.0)

0.271

0.602

Preoperative investigations

 Metabolic acidosis n (%)

10 (33.3%)

14 (46.7%)

1.111

0.292

 Hemoglobin < 6.0 mmol/l n (%)

11 (36.7%)

10 (33.3%)

0.073

0.787

 Creatinine > 110/130 µmol/l n (%)

6 (20%)

8 (26.7%)

0.373

0.542

 Albumin < 550 µmol/l n (%)

9 (30%)

10 (33.3%)

0.077

0.781

Site of perforation

 Stomach n (%)

3 (10.0)

2 (6.7)

0.218

0.640

 Duodenum n (%)

27 (90.0)

28 (93.3)

Size of ulcer

 < 5 mm n (%)

25 (83.3)

24 (80.0)

0.111

0.739

 ≥ 5 mm n (%)

5 (16.7)

6 (20.0)

Duration of symptoms

 ≥ 24 h n (%)

18 (60.0)

20 (66.7)

4.286

0.788

 < 24 h n (%)

12 (40.0)

10 (33.3)

Duration of operation

 < 2 s n (%)

19 (63.3)

19 (63.3)

1.048

0.592

 2–4 h n (%)

10 (33.3)

11 (36.7)

 > 4 h n (%)

1 (3.3)

0 (0.0)